Literature DB >> 11345136

Growth rate of pancreatic adenocarcinoma: initial clinical experience.

H Furukawa1, R Iwata, N Moriyama.   

Abstract

A better understanding of the growth rate of pancreatic carcinoma is important in determining its natural course and in evaluating the effects of treatment or prognosis. The authors studied the growth rate of pancreatic carcinoma and the relation between its tumor volume doubling time (TVDT) and host survival. Nine patients with pancreatic carcinoma who underwent serial examinations by helical computed tomography but no anticancer treatment during the observation period were included. The TVDTs were calculated by measuring the tumor size on the helical computed tomograms. The mean TVDT of the nine primary lesions of pancreatic carcinoma was 159 +/- 67 days (median, 144 days), and the range was 64 to 255 days. The correlation between TVDT and survival time was positive and significant (r = 0.793, p = 0.011). This preliminary study suggests that examination of TVDT may be useful in the clinical evaluation of prognosis for patients with pancreatic carcinoma in certain situations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11345136     DOI: 10.1097/00006676-200105000-00005

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  17 in total

1.  Growth process of small pancreatic carcinoma: a case report with imaging observation for 22 months.

Authors:  Takeshi Hisa; Hiroki Ohkubo; Satoshi Shiozawa; Hiroki Ishigame; Masato Takamatsu; Masayuki Furutake; Bunsei Nobukawa; Koichi Suda
Journal:  World J Gastroenterol       Date:  2008-03-28       Impact factor: 5.742

2.  Estimation of Solid Tumor Doubling Times from Progression-Free Survival Plots Using a Novel Statistical Approach.

Authors:  Katherine Kay; Keith Dolcy; Robert Bies; Dhaval K Shah
Journal:  AAPS J       Date:  2019-02-08       Impact factor: 4.009

3.  CA19-9-related tumor kinetics after first-line chemotherapy of patients with advanced pancreatic cancer: a monoinstitutional experience.

Authors:  Giuseppe Colloca; Antonella Venturino; Domenico Guarneri
Journal:  Med Oncol       Date:  2016-08-13       Impact factor: 3.064

4.  Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma.

Authors:  Jong Kwan Kim; Hyung-Don Kim; Mi-Jung Jun; Sung-Cheol Yun; Ju Hyun Shim; Han Chu Lee; Danbi Lee; Jihyun An; Young-Suk Lim; Young-Hwa Chung; Yung Sang Lee; Kang Mo Kim
Journal:  Dig Dis Sci       Date:  2017-08-16       Impact factor: 3.199

5.  Pancreatic cancer: Slow progression in the early stages.

Authors:  Tsukasa Nakamura; Koji Masuda; Shumpei Harada; Kiyokazu Akioka; Hirotaka Sako
Journal:  Int J Surg Case Rep       Date:  2013-05-22

6.  Weight Loss as an Untapped Early Detection Marker in Pancreatic and Periampullary Cancer.

Authors:  Jonathan J Hue; Kavin Sugumar; Ravi K Kyasaram; John Shanahan; Joshua Lyons; Lee M Ocuin; Luke D Rothermel; Jeffrey M Hardacre; John B Ammori; Goutham Rao; Jordan M Winter; Sarah C Markt
Journal:  Ann Surg Oncol       Date:  2021-04-09       Impact factor: 5.344

7.  Demographic and pathologic factor regression to a growth rate model of p16-negative oral cavity squamous cell carcinoma.

Authors:  Jacob G J Wihlidal; Keng Yeow Tay; S Danielle MacNeil; Anthony C Nichols; Kevin Fung; John H J Yoo; Adrian I Mendez
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-08-16

8.  Development of a Physiologically-Based Mathematical Model for Quantifying Nanoparticle Distribution in Tumors.

Authors:  Prashant Dogra; Yao-Li Chuang; Joseph D Butner; Vittorio Cristini; Zhihui Wang
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2019-07

9.  Hepatocellular Carcinoma Demonstrates Heterogeneous Growth Patterns in a Multicenter Cohort of Patients With Cirrhosis.

Authors:  Nicole E Rich; Binu V John; Neehar D Parikh; Ian Rowe; Neil Mehta; Gaurav Khatri; Smitha M Thomas; Munazza Anis; Mishal Mendiratta-Lala; Christopher Hernandez; Mobolaji Odewole; Latha T Sundaram; Venkata R Konjeti; Shishir Shetty; Tahir Shah; Hao Zhu; Adam C Yopp; Yujin Hoshida; Francis Y Yao; Jorge A Marrero; Amit G Singal
Journal:  Hepatology       Date:  2020-10-25       Impact factor: 17.425

10.  Stereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: a pilot trial demonstrating safety.

Authors:  Marie K Gurka; Sean P Collins; Rebecca Slack; Gary Tse; Aline Charabaty; Lisa Ley; Liam Berzcel; Siyuan Lei; Simeng Suy; Nadim Haddad; Reena Jha; Colin D Johnson; Patrick Jackson; John L Marshall; Michael J Pishvaian
Journal:  Radiat Oncol       Date:  2013-03-01       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.